Published by Josh White on 16th March 2022
(Sharecast News) - Specialist drug developer Sareum Holdings updated the market on the development of its 'SDC-1801' - a potential Covid-19 and autoimmune disease treatment - towards first-in-human trials on Wednesday.
URL: http://www.digitallook.com/dl/news/story/32536820/...